Business Description
Hamps Bio Ltd
SIC : 2834
ISIN : INE0QBD01018
Total Employee Number:
75Compare
Compare
Traded in other countries / regions
544312.India IPO Date
2024-12-20Description
Hamps Bio Ltd is an Indian company engaged in the ethical marketing and distribution of pharmaceutical formulation products, operating through two reportable segments. Its pharmaceutical business covers tablets, syrups, capsules, injectables, oils, gels and powders used as medicines and nutritional supplements, and it also manufactures freeze-dried and frozen products such as fruits, vegetables, herbs and flowers. The pharma products segment, comprising both trading and manufacturing of medicines, generates the majority of the company's revenue, while the freeze-dried and frozen foods business forms a smaller secondary segment. The company markets its formulations to healthcare professionals, pharmacies, hospitals and distributors across India, and its food products serve domestic and export customers. Revenue is derived primarily from the sale and distribution of pharmaceutical formulations, supplemented by sales of processed food products.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | 0.51 | |||||
Debt-to-Equity | 0.85 | |||||
Debt-to-EBITDA | 18.82 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | 2.14 | |||||
Beneish M-Score | -2.24 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 13.7 | |||||
3-Year EBITDA Growth Rate | -25.9 | |||||
3-Year Book Growth Rate | 81.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 6.74 | |||||
9-Day RSI | 23.42 | |||||
14-Day RSI | 33.76 | |||||
3-1 Month Momentum % | -10.68 | |||||
6-1 Month Momentum % | 31.43 | |||||
12-1 Month Momentum % | -20.19 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.46 | |||||
Quick Ratio | 0.75 | |||||
Cash Ratio | 0.05 | |||||
Days Inventory | 287.83 | |||||
Days Sales Outstanding | 54.17 | |||||
Days Payable | 58 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 62.66 | |||||
Operating Margin % | -9.24 | |||||
Net Margin % | -8.72 | |||||
EBITDA Margin % | 4.32 | |||||
FCF Margin % | -71.48 | |||||
OCF Margin % | -10.91 | |||||
ROE % | -8.72 | |||||
ROA % | -5.29 | |||||
ROIC % | -6.12 | |||||
3-Year ROIIC % | -11.1 | |||||
ROC (Joel Greenblatt) % | -3.93 | |||||
ROCE % | -3.95 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 2.39 | |||||
PB Ratio | 2.47 | |||||
Price-to-Tangible-Book | 2.87 | |||||
EV-to-EBIT | -59.21 | |||||
EV-to-EBITDA | 73.03 | |||||
EV-to-Revenue | 3.15 | |||||
EV-to-FCF | -4.89 | |||||
Earnings Yield (Greenblatt) % | -1.69 | |||||
FCF Yield % | -29.57 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hamps Bio Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 84.746 | ||
| EPS (TTM) (₹) | -0.848 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 72.58 | ||
| 14-Day RSI | 33.76 | ||
| 14-Day ATR (₹) | 0.591579 | ||
| 20-Day SMA (₹) | 24.801 | ||
| 12-1 Month Momentum % | -20.19 | ||
| 52-Week Range (₹) | 13.36 - 28.82 | ||
| Shares Outstanding (Mil) | 8.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hamps Bio Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hamps Bio Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| 2:1 Stock Split | 2025-09-09 | -- |
Show
Entries
Hamps Bio Ltd Frequently Asked Questions
What is Hamps Bio Ltd(BOM:544312)'s stock price today?
The current price of BOM:544312 is ₹22.95. The 52 week high of BOM:544312 is ₹28.82 and 52 week low is ₹13.36.
When is next earnings date of Hamps Bio Ltd(BOM:544312)?
The next earnings date of Hamps Bio Ltd(BOM:544312) is .
Does Hamps Bio Ltd(BOM:544312) pay dividends? If so, how much?
Hamps Bio Ltd(BOM:544312) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers